Quantitative Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Quantitative Investment Management’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-26,556	Closed	-$163K	–	828
2019 Q2	$163K	Buy	+26,556	New	+$128K	0.01%	589
2019 Q1	–	Sell	-26,000	Closed	-$109K	–	897
2018 Q4	$109K	Buy	+26,000	New	+$132K	0.01%	517
2018 Q3	–	Sell	-76,500	Closed	-$615K	–	976
2018 Q2	$615K	Buy	+76,500	New	+$584K	0.01%	574
2017 Q3	–	Sell	-126,400	Closed	-$858K	–	910
2017 Q2	$858K	Buy	+126,400	New	+$933K	0.01%	590

Other funds holding PGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Quantitative Investment Management's PGNX Position: Q3 2019 in Review

Quantitative Investment Management sold out of Progenics Pharmaceuticals Inc (PGNX) in Q3 2019, closing a stake of 26,556 shares — an estimated $163K sold.

Quantitative Investment Management first reported a position in PGNX in Q2 2017 and held it in 4 quarters. The position peaked at $858K in Q2 2017. 135 funds tracked by Wall St. Rank hold PGNX as of Q3 2019.

Quantitative Investment Management reported no remaining Progenics Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
Quantitative Investment Management sold 26,556 Progenics Pharmaceuticals Inc shares in Q3 2019, an estimated $163K.
Quantitative Investment Management first reported a position in Progenics Pharmaceuticals Inc in Q2 2017 and held it in 4 quarters.
Quantitative Investment Management's Progenics Pharmaceuticals Inc position peaked at $858K in Q2 2017.
135 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q3 2019.

Based on Quantitative Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.